Press Releases

May 03, 2022

Veracyte Announces First Quarter 2022 Financial Results

Read More

May 02, 2022

Envisia Genomic Classifier Highlighted in Updated Clinical Practice Guideline Regarding Idiopathic Pulmonary Fibrosis Diagnosis

Read More

Apr 28, 2022

Veracyte Announces New Urologic Cancer Data To Be Presented at AUA 2022 International Conference

Read More

Apr 26, 2022

Veracyte Announces New Performance Data for the Percepta Nasal Swab Test To Be Presented at ATS 2022 International Conference

Read More

Apr 19, 2022

Veracyte to Release First Quarter 2022 Financial Results on May 3, 2022

Read More

Apr 06, 2022

C2i Genomics Launches C2inform MRD Test to Bring Distributed Cancer Monitoring to Cancer Centers Across Europe

Read More

Mar 01, 2022

Veracyte to Participate in the Cowen 42nd Annual Health Care Conference

Read More

Feb 28, 2022

Veracyte Announces Fourth Quarter and Full-Year 2021 Financial Results

Read More

Feb 28, 2022

Veracyte Appoints Annie McGuire as General Counsel

Read More

Feb 22, 2022

Veracyte Appoints Jonathan Wygant as Chief Accounting Officer

Read More